Litcius/Paper detail

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study

Anne M. Fagan, Rachel L. Henson, Yan Li, Anna H. Boerwinkle, Chengjie Xiong, Randall J. Bateman, Alison Goate, Beau M. Ances, Eric Doran, Bradley T. Christian, Florence Lai, H. Diana Rosas, Nicole Schupf, Sharon J. Krinsky‐McHale, Wayne Silverman, Joseph H. Lee, William E. Klunk, Benjamin L. Handen, Ricardo Allegri, Jasmeer P. Chhatwal, Gregory S. Day, Neill R. Graff‐Radford, Mathias Jucker, Johannes Levin, Ralph N. Martins, Colin L. Masters, Hiroshi Mori, Catherine J. Mummery, Yoshiki Niimi, John M. Ringman, Stephen Salloway, Peter R. Schofield, Mikio Shoji, Ira T. Lott

2021The Lancet Neurology68 citationsDOIOpen Access PDF

Topics & Concepts

Down syndromeBiomarkerTrisomyDiseaseChromosome 21DementiaAlzheimer's diseaseMedicineAmyloid precursor proteinLife expectancyOncologyPathologyGeneticsInternal medicineChromosomeGeneBiologyPsychiatryPopulationEnvironmental healthDown syndrome and intellectual disability researchDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study | Litcius